Allworth Financial’s Pacific Biosciences PACB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.31K | Sell |
2,668
-2,176
| -45% | -$2.7K | ﹤0.01% | 3472 |
|
|
2025
Q1 | $5.52K | Buy |
4,844
+293
| +6% | +$334 | ﹤0.01% | 2698 |
|
|
2024
Q4 | $8.24K | Buy |
4,551
+2,947
| +184% | +$5.34K | ﹤0.01% | 2519 |
|
|
2024
Q3 | $2.73K | Buy |
1,604
+107
| +7% | +$182 | ﹤0.01% | 2828 |
|
|
2024
Q2 | $2.49K | Buy |
1,497
+1,418
| +1,795% | +$2.36K | ﹤0.01% | 2824 |
|
|
2024
Q1 | $297 | Sell |
79
-37
| -32% | -$139 | ﹤0.01% | 3399 |
|
|
2023
Q4 | $1.14K | Sell |
116
-205
| -64% | -$2.01K | ﹤0.01% | 2908 |
|
|
2023
Q3 | $2.68K | Hold |
321
| – | – | ﹤0.01% | 2401 |
|
|
2023
Q2 | $4.27K | Hold |
321
| – | – | ﹤0.01% | 2179 |
|
|
2023
Q1 | $3.72K | Hold |
321
| – | – | ﹤0.01% | 2151 |
|
|
2022
Q4 | $2.63K | Buy |
321
+43
| +15% | +$352 | ﹤0.01% | 2137 |
|
|
2022
Q3 | $2K | Hold |
278
| – | – | ﹤0.01% | 2197 |
|
|
2022
Q2 | $1K | Buy |
278
+36
| +15% | +$129 | ﹤0.01% | 2220 |
|
|
2022
Q1 | $2K | Hold |
242
| – | – | ﹤0.01% | 1812 |
|
|
2021
Q4 | $5K | Hold |
242
| – | – | ﹤0.01% | 1558 |
|
|
2021
Q3 | $6K | Hold |
242
| – | – | ﹤0.01% | 1485 |
|
|
2021
Q2 | $8K | Hold |
242
| – | – | ﹤0.01% | 1106 |
|
|
2021
Q1 | $8K | Hold |
242
| – | – | ﹤0.01% | 1039 |
|
|
2020
Q4 | $6K | Hold |
242
| – | – | ﹤0.01% | 949 |
|
|
2020
Q3 | $2K | Hold |
242
| – | – | ﹤0.01% | 1010 |
|
|
2020
Q2 | $1K | Hold |
242
| – | – | ﹤0.01% | 1120 |
|
|
2020
Q1 | $1K | Hold |
242
| – | – | ﹤0.01% | 1166 |
|
|
2019
Q4 | $1K | Buy |
+242
| New | +$1K | ﹤0.01% | 1000 |
|